Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00058526
Status:
COMPLETED
Last Update Posted:
2017-05-15
First Post:
2003-04-07
Brief Title:
A Dose-escalation Vaccine Trial in HER2-overexpressing Patients With High-risk Breast Cancer
Sponsor:
Organization:
GlaxoSmithKline